| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/16/2009 | US20090181085 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 07/16/2009 | US20090181069 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 07/16/2009 | US20090181029 Methods for treating interleukin-6 related diseases |
| 07/16/2009 | US20090181000 Methods for the Dietary Management of Irritable Bowel Syndrome and Carbohydrate Malabsorption |
| 07/16/2009 | US20090180956 Diagnostic for evaluating gastric evacuation function and/or small intestinal absorption function |
| 07/16/2009 | CA2738458A1 Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
| 07/16/2009 | CA2711840A1 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy |
| 07/16/2009 | CA2711029A1 Anti mif antibodies |
| 07/16/2009 | CA2702012A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 07/16/2009 | CA2676477A1 Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
| 07/15/2009 | EP2078718A1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 07/15/2009 | EP2078523A1 Agent for suppression of gastric emptying comprising 4-hydroxyisoleucine |
| 07/15/2009 | EP2077840A1 Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof |
| 07/15/2009 | EP2077828A2 Treatment of hepatic encephalopathy and liver cirrhosis |
| 07/15/2009 | EP2005962A9 Therapeutic agent for inflammatory bowel disease |
| 07/15/2009 | EP1519746B1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 07/15/2009 | EP1517989B1 Method for the diagnosing of sphingolipid metabolism |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1141015B1 Insulin-like growth factor (igf) i mutant variants |
| 07/15/2009 | CN101481405A Somatostatin-dopamine chimeric analogs |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN100513570C Regulation effect of conjugated frame transport protein ABC1 |
| 07/15/2009 | CN100513406C Novel quinuclidine derivatives and their use |
| 07/15/2009 | CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 07/15/2009 | CN100512815C Matrine enteric coatel tablet and its preparation method |
| 07/15/2009 | CN100512811C Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 07/15/2009 | CN100512809C Compounds and methods of treating transplant rejection |
| 07/14/2009 | US7560591 Benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 07/14/2009 | US7560558 quinoline pyridyl derivatives antagonist; antitumor agents; renal disease, hepatic fibrosis, cirrhosis, fibroid lung, scleroderma, wound healing, arthritis, congestive cardiac disease, ulcer, ocular disorder, cornea disorder, diabetic nephropathy |
| 07/14/2009 | US7560548 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560527 Modified adenovirus fibre and uses |
| 07/14/2009 | US7560479 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 07/14/2009 | US7560473 Amine derivative with potassium channel regulatory function, its preparation and use |
| 07/14/2009 | US7560472 1-cyclohexylethyl ammonium salts; for inhibiting gastric juice secretion |
| 07/14/2009 | US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy |
| 07/14/2009 | CA2382302C A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis |
| 07/14/2009 | CA2379841C Biphenyl derivatives, the preparation thereof and their use as medicaments |
| 07/09/2009 | WO2009084653A1 Method for screening of cell-protecting agent |
| 07/09/2009 | WO2009084482A1 Composition comprising sesamin component and quercetin glycoside |
| 07/09/2009 | WO2009084232A1 Sugar chain-related gene and use thereof |
| 07/09/2009 | WO2009083738A2 Rna delivery vehicles |
| 07/09/2009 | WO2009083155A1 Substance containing at least one active ingredient that has a gum-growing effect |
| 07/09/2009 | WO2009057811A3 Heterocyclic compound and pharmaceutical composition thereof |
| 07/09/2009 | WO2009023355A3 Compositions and methods for reducing the toxicity of certain toxins |
| 07/09/2009 | WO2008052468A8 New lactobacillus rhamnosus strain, its pharmaceutical composition and the uses thereof, and the method for preparation |
| 07/09/2009 | US20090176857 Use of Organic Compounds |
| 07/09/2009 | US20090176853 Adamantane derivatives |
| 07/09/2009 | US20090176817 Method of Treatment of Diarrhea-Predominant Irritable Bowel Syndrome in a Subject |
| 07/09/2009 | US20090176808 combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 07/09/2009 | US20090176803 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists |
| 07/09/2009 | US20090176748 Methods and compositions for controlled release oral dosage of a vitamin d compound |
| 07/09/2009 | US20090176741 Modulation of the immune system by inositol phospholipids |
| 07/09/2009 | US20090176730 N4-acylcytosine nucleosides for treatment of viral infections |
| 07/09/2009 | US20090175965 Antiscarring, antiaging, photodamaged skin or as a depilatory; unsaponifiable component from canola oil, rapeseed oil, sunflower oil, palm oil, maize oil, sesame oil, wheatgerm oil and one from avocado oil, lupin oil, or soybean oil |
| 07/09/2009 | US20090175941 Tablet-form slow-release preparation for vertigo |
| 07/09/2009 | US20090175933 Preparation for the treatment of diarrhoea |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | DE60019555C5 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit 2-oxy-benzoxazinonderivate for treatment of obesity |
| 07/09/2009 | CA2710379A1 Compositions containing sesamin-class compound(s) and quercetin glycoside(s) |
| 07/08/2009 | EP2077267A1 Fused heterocyclic compound |
| 07/08/2009 | EP2077265A1 Salt of sulfinylbenzimidazole compound, and crystal and amorphous form thereof |
| 07/08/2009 | EP2077262A1 Iminopyridine derivative and use thereof |
| 07/08/2009 | EP2077260A1 Amide compound or salt thereof, and biofilm formation inhibitor, biofilm remover and bactericide each using the amide compound or salt thereof |
| 07/08/2009 | EP2077122A1 Therapeutic agents for irritable bowel syndrome |
| 07/08/2009 | EP2077109A1 Amide compound, salt thereof, and biofilm remover using them |
| 07/08/2009 | EP2076277A2 Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating nf-kappab or suppressing nf-kappab-mediated actions |
| 07/08/2009 | EP2076271A1 Inhibition of cholera toxins by galatooligosaccharides (gos) |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | EP1435918B1 Highly compressible ethylcellulose for tableting |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1301592B1 Recombinant bacterial phytases and uses thereof |
| 07/08/2009 | EP0738142B1 Perfluorocarbons as anti-inflammatory agents |
| 07/08/2009 | CN101479008A Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower HDL-C and lower cholesterol |
| 07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 07/08/2009 | CN100510073C Tryptase inhibitor |
| 07/08/2009 | CN100509843C Acid-modified arabinogalactan protein composition |
| 07/08/2009 | CN100509810C Substituted beta-carbolines |
| 07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 07/08/2009 | CN100509797C Thiophene derivatives used as antiviral agent against flavivirus infections |
| 07/08/2009 | CN100509789C Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 07/08/2009 | CN100509782C NK* antagonists |
| 07/08/2009 | CN100509773C Alpha -amino-n-hydroxy-acetamide derivatives |
| 07/08/2009 | CN100509057C Antigen arrays for treatment of bone disease |
| 07/08/2009 | CN100509047C Combination of medication for treating hepatitis B and preparation method thereof |
| 07/08/2009 | CN100509042C Combination of medication for treating gastric disease and preparing method thereof |
| 07/08/2009 | CN100509015C Combination of medication for treating gastric ulcer |
| 07/08/2009 | CN100509008C Shutongfang for killing pain and preparation and use thereof |
| 07/08/2009 | CN100508998C Weibingkang for treating stomach disease |
| 07/08/2009 | CN100508997C Korean pine kernel soft capsule and preparing method thereof |
| 07/08/2009 | CN100508993C Enterobacteria containing tablet |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/08/2009 | CN100508965C Dosage forms having prolonged active ingredient release |
| 07/08/2009 | CN100508955C Effervesce tablet of American ginseng containing vitamin C and preparation method thereof |
| 07/07/2009 | US7557210 Antiinflamamtory agents |
| 07/07/2009 | US7557194 Antibody materials for an IBD-associated polypeptide |
| 07/07/2009 | US7557183 Polyethylene glycol linked GLP-1 compounds |
| 07/07/2009 | US7557128 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen |
| 07/07/2009 | US7557117 4-oxoimidazolidine-2-spiropiperidine derivatives |